SCHEMBL7976013

SCHEMBL7976013

CCN(CC)C(=O)/C=C(/C)c1ccc(OCc2cc(Cl)ccc2Cl)c(OCC(=O)O)c1

nearest known ligand 0.81

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 20/20 0.81
LTB4R2 Q9NPC1 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7976005 1.00 LTB4R (0.81) LTB4RLTB4R2
SCHEMBL7976014 1.00 LTB4R (0.81) LTB4RLTB4R2
SCHEMBL7990453 0.93 LTB4R (0.81) LTB4RLTB4R2
SCHEMBL7990449 0.93 LTB4R (0.81) LTB4RLTB4R2
SCHEMBL7990456 0.93 LTB4R (0.81) LTB4RLTB4R2
SCHEMBL7990179 0.90 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7990177 0.90 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7990180 0.90 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7986872 0.85 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7986874 0.85 LTB4R (1.00) LTB4RLTB4R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291530-B1 Aryl-substituted acrylamides with Leukotriene B4 (LTB-4) receptor antagonist activity NOVARTIS AG (CH) 2001-09-18 US disclosed
EP-0942903-A1 ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY Novartis AG (CH) 1999-09-22 EP disclosed
WO-1998013347-A1 ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY NOVARTIS AG (CH) 1998-04-02 WO disclosed